Cargando…

Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real‐world evidence study

PURPOSE: Helicobacter pylori (H. pylori) is a major risk factor for gastric cancer and may affect androgen activity in men. The association between H. pylori and androgen deprivation therapy (ADT) in patients with prostate cancer (PCa) remains unclear. METHODS: This retrospective cohort study linked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jui‐Ming, Wu, Chun‐Te, Hsu, Ren‐Jun, Hsu, Wen‐Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607261/ https://www.ncbi.nlm.nih.gov/pubmed/34590436 http://dx.doi.org/10.1002/cam4.4318

Ejemplares similares

Decreased Risk of Renal Calculi in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2020)

Association between medical androgen deprivation therapy and long‐term cardiovascular disease and all‐cause mortality in nonmetastatic prostate cancer
por: Forster, Rachel B., et al.
Publicado: (2022)

Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study
por: Tae, Bum Sik, et al.
Publicado: (2019)

Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan
por: Uno, Yoshiharu
Publicado: (2019)

Helicobacter pylori‐related risk predictors of gastric cancer: The latest models, challenges, and future prospects
por: Bakhti, Seyedeh Zahra, et al.
Publicado: (2020)

Inverse association of Helicobacter pylori cagPAI genotypes with risk of cardia and non‐cardia gastric adenocarcinoma
por: Bakhti, Seyedeh Zahra, et al.
Publicado: (2019)

Additive interactions between PRKAA1 polymorphisms and Helicobacter pylori CagA infection associated with gastric cancer risk in Koreans
por: Eom, Sang‐Yong, et al.
Publicado: (2016)

Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders
por: Liu, Jui-Ming, et al.
Publicado: (2020)

Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population‐based analysis
por: Lai, Yen‐Ling, et al.
Publicado: (2021)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Waist circumference and a body shape index and prostate cancer risk and mortality
por: Jochems, Sylvia H. J., et al.
Publicado: (2021)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

A real‐world, population‐based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer
por: Abdel‐Rahman, Omar, et al.
Publicado: (2018)

HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2022)

Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation
por: Baker, Hailey A., et al.
Publicado: (2018)

A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real‐world experience
por: Li, Xiaona, et al.
Publicado: (2020)

No increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: a 17-year population-based study
por: Liu, Jui-Ming, et al.
Publicado: (2018)

Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non‐small cell lung cancer
por: Wang, Chengdi, et al.
Publicado: (2019)

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer
por: Liu, Jui-Ming, et al.
Publicado: (2021)

Profiling of Skeletal Muscle and Adipose Tissue Depots in Men with Advanced Prostate Cancer Receiving Different Forms of Androgen Deprivation Therapy
por: Blow, Tahj A., et al.
Publicado: (2023)

Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib‐based combination therapy: A real‐world experience of off‐label ibrutinib use
por: Chen, Feili, et al.
Publicado: (2020)

African‐American men and prostate cancer‐specific mortality: a competing risk analysis of a large institutional cohort, 1989–2015
por: Williams, Vonetta L., et al.
Publicado: (2018)

Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry
por: Bluethmann, Shirley M., et al.
Publicado: (2020)

Current trend of worsening prognosis of prostate small cell carcinoma: A population‐based study
por: Wang, Jili, et al.
Publicado: (2019)

Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and pancreatic cancer incidence and mortality: A prospective cohort study
por: Zhang, Zhi‐Qing, et al.
Publicado: (2020)

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
por: Chi, Jen‐Tsan, et al.
Publicado: (2020)

Impact of serious mental illness on the treatment and mortality of older patients with locoregional high‐grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER‐Medicare patients diagnosed between 2006 and 2013
por: Fried, Dennis A., et al.
Publicado: (2019)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Real‐world outcomes of advanced melanoma patients not represented in phase III trials
por: van Zeijl, Michiel C. T., et al.
Publicado: (2020)

The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

A mortality study of beryllium workers
por: Boffetta, Paolo, et al.
Publicado: (2016)

Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study
por: Shahabi, Ahva, et al.
Publicado: (2014)

Depression and prostate cancer risk: A Mendelian randomization study
por: Chen, Xiong, et al.
Publicado: (2020)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns
por: Fokom Domgue, Joël, et al.
Publicado: (2020)

AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer
por: Zhou, Jiatong, et al.
Publicado: (2020)

Associations between prostate cancer‐related anxiety and health‐related quality of life
por: Erim, Daniel O., et al.
Publicado: (2020)

Prostate cancer risk in patients with melanoma: A systematic review and meta‐analysis
por: Acharya, Prakash, et al.
Publicado: (2020)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ojvs5nlsh458d46d6mnhho8uu4